LG
Logos Global Management LP
San Francisco CA · SEC CIK 0001792126
$2.32B2026Q2 reported value
68Positions
48.3%Top 10 weight · largest 9.6%
18 / 23New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
BNTX New+$94.45M
VERA New+$94.40M
CLDX Added+$61.40M
ABVX Added+$46.51M
DNTH Added+$38.99M
2026Q2 top sells estimated at quarter-end value
RVMD Reduced-$243.46M
CENTESSA PHARMAC Sold out-$84.41M
TERNS PHARMACEUT Sold out-$79.08M
CYTK Sold out-$57.67M
UTHR Sold out-$47.44M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| ERAS | ERASCA INC | $222.59M | 9.58% | 12,150,000 | 1,000,000 | 9.0% | $18.32M | Added |
| ABVX | ABIVAX SA | $136.46M | 5.87% | 1,024,000 | 349,000 | 51.7% | $46.51M | Added |
| RVMD | REVOLUTION MEDICINES INC | $131.10M | 5.64% | 700,000 | -1,300,000 | -65.0% | -$243.46M | Reduced |
| IDYA | IDEAYA BIOSCIENCES INC | $111.81M | 4.81% | 3,000,000 | -450,000 | -13.0% | -$16.77M | Reduced |
| BNTX | BIONTECH SE | $94.45M | 4.07% | 1,015,000 | 1,015,000 | — | $94.45M | New |
| VERA | VERA THERAPEUTICS INC | $94.40M | 4.06% | 2,200,000 | 2,200,000 | — | $94.40M | New |
| TNGX | TANGO THERAPEUTICS INC | $89.09M | 3.84% | 2,850,000 | -150,000 | -5.0% | -$4.69M | Reduced |
| PRAX | PRAXIS PRECISION MEDICINES I | $87.05M | 3.75% | 260,000 | -25,000 | -8.8% | -$8.37M | Reduced |
| CLDX | CELLDEX THERAPEUTICS INC NEW | $78.14M | 3.36% | 2,100,000 | 1,650,000 | 366.7% | $61.40M | Added |
| DNTH | DIANTHUS THERAPEUTICS INC | $77.98M | 3.36% | 800,000 | 400,000 | 100.0% | $38.99M | Added |
| CGON | CG ONCOLOGY INC | $71.05M | 3.06% | 1,000,000 | 425,000 | 73.9% | $30.20M | Added |
| IRON | DISC MEDICINE INC | $64.00M | 2.76% | 875,000 | 315,000 | 56.2% | $23.04M | Added |
| MAZE | MAZE THERAPEUTICS INC | $57.74M | 2.49% | 1,935,000 | 700,000 | 56.7% | $20.89M | Added |
| DYN | DYNE THERAPEUTICS INC | $56.64M | 2.44% | 2,550,000 | 1,150,000 | 82.1% | $25.54M | Added |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $52.08M | 2.24% | 2,675,000 | 1,175,000 | 78.3% | $22.88M | Added |
| OCUL | OCULAR THERAPEUTIX INC | $52.05M | 2.24% | 5,300,000 | 1,450,000 | 37.7% | $14.24M | Added |
| DSGN | DESIGN THERAPEUTICS INC | $43.41M | 1.87% | 3,000,000 | 1,050,000 | 53.8% | $15.19M | Added |
| OLMA | OLEMA PHARMACEUTICALS INC | $40.14M | 1.73% | 3,208,875 | 0 | 0.0% | — | Unchanged |
| BLTE | BELITE BIO INC | $38.50M | 1.66% | 250,000 | 250,000 | — | $38.50M | New |
| ACHV | ACHIEVE LIFE SCIENCE INC | $35.43M | 1.53% | 5,425,000 | 5,425,000 | — | $35.43M | New |
| TRVI | TREVI THERAPEUTICS INC | $35.06M | 1.51% | 1,880,000 | -520,000 | -21.7% | -$9.70M | Reduced |
| COGT | COGENT BIOSCIENCES INC | $34.83M | 1.50% | 900,000 | 900,000 | — | $34.83M | New |
| AVBP | ARRIVENT BIOPHARMA INC | $34.74M | 1.50% | 1,000,000 | 650,000 | 185.7% | $22.58M | Added |
| CBIO | CRESCENT BIOPHARMA INC. | $34.20M | 1.47% | 1,900,000 | 1,417,500 | 293.8% | $25.52M | Added |
| CMPS | COMPASS PATHWAYS PLC | $31.84M | 1.37% | 2,250,000 | 2,250,000 | — | $31.84M | New |
| MLYS | MINERALYS THERAPEUTICS INC | $28.33M | 1.22% | 1,050,000 | 1,050,000 | — | $28.33M | New |
| REPL | REPLIMUNE GROUP INC | $27.68M | 1.19% | 2,500,000 | 2,500,000 | — | $27.68M | New |
| XENE | XENON PHARMACEUTICALS INC | $27.16M | 1.17% | 450,000 | 0 | 0.0% | — | Unchanged |
| GPCR | STRUCTURE THERAPEUTICS INC | $26.84M | 1.16% | 500,000 | 0 | 0.0% | — | Unchanged |
| IMVT | IMMUNOVANT INC | $25.62M | 1.10% | 665,000 | -410,000 | -38.1% | -$15.80M | Reduced |
| JBIO | JADE BIOSCIENCES INC | $25.00M | 1.08% | 1,125,000 | 725,000 | 181.2% | $16.11M | Added |
| ELVN | ENLIVEN THERAPEUTICS INC | $23.60M | 1.02% | 465,000 | -75,000 | -13.9% | -$3.81M | Reduced |
| MANE | VERADERMICS INC | $22.13M | 0.95% | 180,000 | 155,000 | 620.0% | $19.06M | Added |
| AVTX | AVALO THERAPEUTICS INC | $21.25M | 0.91% | 1,150,000 | 850,000 | 283.3% | $15.71M | Added |
| RCUS | ARCUS BIOSCIENCES INC | $20.04M | 0.86% | 650,000 | -550,000 | -45.8% | -$16.96M | Reduced |
| SMMT | SUMMIT THERAPEUTICS INC | $19.67M | 0.85% | 1,350,000 | 1,350,000 | — | $19.67M | New |
| IMCR | IMMUNOCORE HLDGS PLC | $19.05M | 0.82% | 600,000 | -900,000 | -60.0% | -$28.57M | Reduced |
| LBRX | LB PHARMACEUTICALS INC | $18.99M | 0.82% | 585,000 | -330,000 | -36.1% | -$10.71M | Reduced |
| NERV | MINERVA NEUROSCIENCES INC | $18.25M | 0.79% | 3,288,777 | 73,777 | 2.3% | $409,462 | Added |
| FTH | FAETH THERAPEUTICS INC | $18.05M | 0.78% | 722,020 | 692,020 | 2,306.7% | $17.30M | Added |
| CRSP | CRISPR THERAPEUTICS AG | $16.36M | 0.70% | 300,000 | 300,000 | — | $16.36M | New |
| DBVT | DBV TECHNOLOGIES S A | $15.01M | 0.65% | 915,000 | 890,000 | 3,560.0% | $14.60M | Reappeared |
| PBLS | PARABILIS MEDICINES INC | $14.37M | 0.62% | 525,000 | 525,000 | — | — | First reported |
| RYTM | RHYTHM PHARMACEUTICALS INC | $13.88M | 0.60% | 125,000 | -325,000 | -72.2% | -$36.08M | Reduced |
| VOR | VOR BIOPHARMA INC | $11.97M | 0.52% | 650,000 | -100,000 | -13.3% | -$1.84M | Reduced |
| SRRK | SCHOLAR ROCK HLDG CORP | $11.00M | 0.47% | 200,000 | 200,000 | — | $11.00M | New |
| IMMX | IMMIX BIOPHARMA INC | $10.31M | 0.44% | 1,000,000 | -225,000 | -18.4% | -$2.32M | Reduced |
| QTTB | Q32 BIO INC | $10.19M | 0.44% | 800,000 | 800,000 | — | $10.19M | New |
| ODTX | ODYSSEY THERAPEUTICS INC | $9.76M | 0.42% | 521,736 | 521,736 | — | — | First reported |
| ANNX | ANNEXON INC | $8.56M | 0.37% | 1,500,000 | 1,500,000 | — | $8.56M | New |
| EDIT | EDITAS MEDICINE INC | $7.20M | 0.31% | 2,222,000 | 2,222,000 | — | $7.20M | New |
| RLAY | RELAY THERAPEUTICS INC | $6.55M | 0.28% | 350,000 | -400,000 | -53.3% | -$7.48M | Reduced |
| ACAD | ACADIA PHARMACEUTICALS INC | $6.33M | 0.27% | 250,000 | -500,000 | -66.7% | -$12.65M | Reduced |
| AMLX | AMYLYX PHARMACEUTICALS INC | $6.29M | 0.27% | 350,000 | -350,000 | -50.0% | -$6.29M | Reduced |
| — | CYBIN INC | $4.96M | 0.21% | 750,000 | 750,000 | — | $4.96M | New |
| OKUR | ONKURE THERAPEUTICS INC | $4.40M | 0.19% | 963,855 | 963,855 | — | $4.40M | New |
| TENX | TENAX THERAPEUTICS INC | $4.37M | 0.19% | 300,000 | -325,000 | -52.0% | -$4.73M | Reduced |
| DFTX | DEFINIUM THERAPEUTICS INC | $3.76M | 0.16% | 80,000 | 80,000 | — | $3.76M | New |
| — | UNICYCIVE THERAPEUTICS INC | $2.22M | 0.10% | 473,563 | 0 | 0.0% | — | Unchanged |
| — | PALATIN TECHNOLOGIES INC | $1.40M | 0.06% | 130,000 | -10,000 | -7.1% | -$107,900 | Reduced |
| QURE | UNIQURE NV | $1.38M | 0.06% | 30,000 | -645,000 | -95.6% | — | Reappeared |
| — | JATT II ACQUISITION CORP | $1.14M | 0.05% | 100,000 | 100,000 | — | — | First reported |
| — | RESEARCH ALLIANCE CORP III | $1.07M | 0.05% | 100,000 | 100,000 | — | — | First reported |
| ACRS | ACLARIS THERAPEUTICS INC | $1.06M | 0.05% | 200,000 | -300,000 | -60.0% | -$1.59M | Reduced |
| — | LONGEVERON INC | $904,761 | 0.04% | 1,287,000 | 1,287,000 | — | $904,761 | New |
| — | FRACTYL HEALTH INC | $794,400 | 0.03% | 1,000,000 | 0 | 0.0% | — | Unchanged |
| SEPN | SEPTERNA INC | $788,623 | 0.03% | 23,548 | 0 | 0.0% | — | Unchanged |
| — | AMANAT ACQUISITION CORP | $508,000 | 0.02% | 50,000 | 50,000 | — | — | First reported |
| — | CENTESSA PHARMACEUTICALS PLC | $0 | 0.00% | 0 | -2,125,000 | -100.0% | -$84.41M | Sold out |
| — | TERNS PHARMACEUTICALS INC | $0 | 0.00% | 0 | -1,500,000 | -100.0% | -$79.08M | Sold out |
| CYTK | CYTOKINETICS INC | $0 | 0.00% | 0 | -875,000 | -100.0% | -$57.67M | Sold out |
| UTHR | UNITED THERAPEUTICS CORP DEL | $0 | 0.00% | 0 | -80,000 | -100.0% | -$47.44M | Sold out |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $0 | 0.00% | 0 | -85,000 | -100.0% | -$44.49M | Sold out |
| BIIB | BIOGEN INC | $0 | 0.00% | 0 | -200,000 | -100.0% | -$36.67M | Sold out |
| TYRA | TYRA BIOSCIENCES INC | $0 | 0.00% | 0 | -850,000 | -100.0% | -$32.55M | Sold out |
| — | TERNS PHARMACEUTICALS INC Call | $0 | 0.00% | 0 | -500,000 | -100.0% | -$26.36M | Sold out |
| ELVN | ENLIVEN THERAPEUTICS INC Call | $0 | 0.00% | 0 | -500,000 | -100.0% | -$19.60M | Sold out |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | $0 | 0.00% | 0 | -600,000 | -100.0% | -$19.21M | Sold out |
| MIRM | MIRUM PHARMACEUTICALS INC | $0 | 0.00% | 0 | -200,000 | -100.0% | -$18.48M | Sold out |
| PCVX | VAXCYTE INC | $0 | 0.00% | 0 | -300,000 | -100.0% | -$17.43M | Sold out |
| CMPX | COMPASS THERAPEUTICS INC | $0 | 0.00% | 0 | -3,150,000 | -100.0% | -$16.66M | Sold out |
| AVTX | AVALO THERAPEUTICS INC Call | $0 | 0.00% | 0 | -1,000,000 | -100.0% | -$14.93M | Sold out |
| JANX | JANUX THERAPEUTICS INC | $0 | 0.00% | 0 | -1,000,000 | -100.0% | -$13.90M | Sold out |
| ALKS | ALKERMES PLC | $0 | 0.00% | 0 | -350,000 | -100.0% | -$12.38M | Sold out |
| ORIC | ORIC PHARMACEUTICALS INC | $0 | 0.00% | 0 | -950,000 | -100.0% | -$12.04M | Sold out |
| — | SOLENO THERAPEUTICS INC | $0 | 0.00% | 0 | -250,000 | -100.0% | -$8.37M | Sold out |
| CRVS | CORVUS PHARMACEUTICALS INC | $0 | 0.00% | 0 | -450,000 | -100.0% | -$6.58M | Sold out |
| MGTX | MEIRAGTX HLDGS PLC | $0 | 0.00% | 0 | -700,000 | -100.0% | -$6.06M | Sold out |
| VSTM | VERASTEM INC | $0 | 0.00% | 0 | -1,000,000 | -100.0% | -$5.30M | Sold out |
| — | IBIO INC | $0 | 0.00% | 0 | -1,300,000 | -100.0% | -$2.47M | Sold out |
| PHVS | PHARVARIS N V | $0 | 0.00% | 0 | -65,000 | -100.0% | -$1.84M | Sold out |